These results partially correspond with results of Jørgensen et al. (26), where CVID patients with complications, and/or with decreased plasma IgA levels also had reduced alpha-diversity when compared with patients suffering from infections only, and/or with normal plasma IgA levels. This evidence concerns the gene CD79A and common variable immunodeficiency.